Federal Motor Carrier Safety Administration. 49 CFR Parts 385, 386, 390, and 395. Electronic Logging Devices and Hours of Service Supporting Documents; Final Rule. tkelley on DSK9F6TC42PROD with RULES2 VerDate Sep<11>2014 18:38 Dec 15, 2015 Jkt 238001 PO 00000 Frm 00001 Fmt 4717 Sfmt 4717 E:\FR\FM\16DER2.SGM 16DER2.
Print, Download, Order. Rituximab is given through a drip into a vein (intravenous infusion) in hospital. The first infusion takes around six hours, although following infusions will take a bit less time. Usually two infusions are given two weeks apart. This process is repeated when the improvement is wearing off (from around six months to three years later). Many people have rituximab about once a year.
Rituxan (rituximab) is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Rituxan is used to treat non-Hodgkin's lymphoma or chronic lymphocytic leukemia. Rituxan is also used in combination with another drug called methotrexate to treat symptoms of adult rheumatoid arthritis. Rituxan is also used in combination with steroid medicines to treat certain rare disorders that cause inflammation of blood vessels and other tissues in the body.